2018
DOI: 10.1002/admt.201800349
|View full text |Cite
|
Sign up to set email alerts
|

Surface Modifying Doped Silicon Nanowire Based Solar Cells for Applications in Biosensing

Abstract: ADP -ammonium dihydrogen phosphate, antiPSA -monoclonal antibodies specific for PSA, APTES -(3 aminopropyl) triethoxysilane, BSF -back surface field, BSA -bovine serum albumin, DNAdeoxyribonucleic acid, EDC -1-ethyl-3-(3-dimethylaminopropyl) carbodiimide, ELISA -Enzyme Linked Immunosorbent Assay, EQE -external quantum efficiency, FET-field effect transistors, MACEmetal assisted chemical etching, , NW -nanowire, PBS -Phosphate Buffered Saline, PC -Prostate cancer, PCR -polymerase chain reaction, pI-Isoelectric … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
21
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
3
1

Relationship

2
8

Authors

Journals

citations
Cited by 22 publications
(22 citation statements)
references
References 45 publications
1
21
0
Order By: Relevance
“…In this manuscript, we present results on a scalable bioelectronic sensor platform, which converts the binding of target biomolecules to electrical signals in a rapid and compact formfactor, enabling POC testing of viruses, such as COVID-19, by minimally trained individuals qualifying it for eventual CLIA waiver certification. Our biosensor architecture is based on silicon nanowires (SiNWs) that various teams [ 19 , 20 ] including ours [ 21 ] have demonstrated to have higher sensitivity than planar Si biosensors because of the high surface-to-volume ratio of the SiNWs. However, not all SiNWs-based biosensors are suited for COVID-19 detection, because their manufacturing steps are not complementary metal oxide semiconductor (CMOS) compatible while also being low-yield, slow, and require high-cost equipment [ [22] , [23] , [24] , [25] ].…”
Section: Introductionmentioning
confidence: 99%
“…In this manuscript, we present results on a scalable bioelectronic sensor platform, which converts the binding of target biomolecules to electrical signals in a rapid and compact formfactor, enabling POC testing of viruses, such as COVID-19, by minimally trained individuals qualifying it for eventual CLIA waiver certification. Our biosensor architecture is based on silicon nanowires (SiNWs) that various teams [ 19 , 20 ] including ours [ 21 ] have demonstrated to have higher sensitivity than planar Si biosensors because of the high surface-to-volume ratio of the SiNWs. However, not all SiNWs-based biosensors are suited for COVID-19 detection, because their manufacturing steps are not complementary metal oxide semiconductor (CMOS) compatible while also being low-yield, slow, and require high-cost equipment [ [22] , [23] , [24] , [25] ].…”
Section: Introductionmentioning
confidence: 99%
“…More extensive assessment of CQAs will require more extensive measurements. Recent efforts include: 1) a combination of refractive index and multiple spectroscopic detectors, 140 analyzed using a multivariate partial least squares regression model; 2) label-free inline detection of product aggregates using hydrogel-encapsulated NIR fluorescence nanosensors 141 and of protein impurities using sensitive and inexpensive silicon nanowire biosensors; 142 3) a continuous-flow nanofluidic device 143 for the measurement of macromolecular size, folding, and binding activity; 4) and a low-cost aptamer-based molecular turn-on assay that also monitors mAb concentration in real-time, with the ability to distinguish between native and heat-treated mAb. 144 Such innovations in sensor development are necessary not only for implementation in continuous manufacturing, but also to generate large data sets needed to improve process understanding.…”
Section: Process Analytical Technologiesmentioning
confidence: 99%
“…Silicon nanowire field-effect transistors have been previously used to provide labelfree, real-time detection of proteins [47], DNA [48] and even single virions [49]; however, issues with sensitivity in physiologically relevant substrates and high manufacturing costs has hampered furthering this technology [50]. These issues have largely been solved in a variety of ways on a laboratory scale [51][52][53], thus employing these approaches toward SARS-CoV-2 detection (protein or genetic) is possible and could result in technologies that fill an important void in the current spectrum of testing methodologies.…”
Section: Novel Sars-cov-2 Sensingmentioning
confidence: 99%